ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
国药控股ADR
13.97
+0.1500
1.09%
成交量:
9.58万
成交额:
134.29万
市值:
87.19亿
市盈率:
8.94
高:
14.46
开:
13.93
低:
13.42
收:
13.82
52周最高:
14.87
52周最低:
10.72
股本:
6.24亿
流通股本:
2.68亿
量比:
2.55
换手率:
0.04%
股息:
0.49
股息率:
3.54%
每股收益(TTM):
1.56
每股收益(LYR):
1.55
净资产收益率:
7.83%
总资产收益率:
2.54%
市净率:
0.73
市盈率(LYR):
9.03
数据加载中...
总览
公司
新闻资讯
公告
国药控股与天士力医药集团达成战略合作 共筑“战略一体化服务”生态新标杆
国药控股
·
2025/12/25
刚刚!国药控股董事长正式官宣
制药在线
·
2025/12/22
122亿!国药控股大合作来了
中食药信息网
·
2025/12/04
国药控股(湖南)医药创新产业园即将投产
红网
·
2025/12/04
复宏汉霖重续与国药控股经销协议 年度上限逐年递增
财中社
·
2025/12/04
国药控股董事长换人!
制药在线
·
2025/12/01
美国OTC市场国药控股盘中异动 股价大涨5.44%报13.67美元
市场透视
·
2025/11/11
国药控股相关公司新增一项122.34万元的招标项目
市场资讯
·
2025/09/04
国药控股天和吉林医药有限公司中标吉林大学第二医院激光光学系统采购项目
DoNews
·
2025/09/04
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/SHTDY/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHTDY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","market":"US","secType":"STK","nameCN":"国药控股ADR","latestPrice":13.97,"timestamp":1771966799718,"preClose":13.82,"halted":0,"volume":95777,"delay":15,"changeRate":0.010853835021707696,"floatShares":268330371,"shares":624131238,"eps":1.563169,"marketStatus":"盘后交易","change":0.15,"latestTime":"02-24 15:59:59 EST 延时","open":13.93,"high":14.46,"low":13.42,"amount":1342930.3404,"amplitude":0.075253,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":1.563169,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1771981200000},"marketStatusCode":4,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":13.82,"volumeRatio":2.551549},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHTDY\",,,,,undefined,":{"symbol":"SHTDY","floatShares":268330371,"roa":"2.54%","roe":"7.83%","lyrEps":1.547539,"volumeRatio":2.551549,"shares":624131238,"dividePrice":0.49417,"high":14.46,"amplitude":0.075253,"preClose":13.82,"low":13.42,"week52Low":10.72,"pbRate":"0.73","psRate":"0.10","week52High":14.87,"institutionHeld":0,"latestPrice":13.97,"eps":1.563169,"divideRate":0.035374,"volume":95777,"delay":15,"ttmEps":1.563169,"open":13.93,"prevYearClose":12.4,"prevWeekClose":13.48,"prevMonthClose":13.3,"prevQuarterClose":12.4,"fiveDayClose":13.7,"twentyDayClose":13.284,"sixtyDayClose":13.185},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHTDY\",params:#limit:5,,,undefined,":[{"date":"2025-06-17","symbol":"SHTDY","amount":0.471279,"announcedDate":"2025-05-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-17","defaultRemindTime":1750167000000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-08-27","payableDate":"2025-06-17","currency":"USD","dateTimestamp":1750132800000,"payDate":"2025-08-27"},{"market":"US","date":"2024-08-22","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1724299200000,"reportTimeType":"post","actualEps":null},{"date":"2024-06-18","symbol":"SHTDY","amount":0.6011,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-18","defaultRemindTime":1718717400000,"name":"国药控股ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-08-28","payableDate":"2024-06-18","currency":"USD","dateTimestamp":1718683200000,"payDate":"2024-08-28"},{"market":"US","date":"2024-04-25","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1714017600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-03-21","symbol":"SHTDY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHTDY\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-17","recordDate":"2016-06-21","paymentDate":"2016-08-30","value":0.246246,"currency":"USD"},{"executeDate":"2019-07-01","recordDate":"2019-07-02","paymentDate":"2019-09-11","value":0.347513,"currency":"USD"},{"executeDate":"2020-06-12","recordDate":"2020-06-15","paymentDate":"2020-08-26","value":0.333835,"currency":"USD"},{"executeDate":"2021-06-14","recordDate":"2021-06-15","paymentDate":"2021-08-25","value":0.427193,"currency":"USD"},{"executeDate":"2022-06-24","recordDate":"2022-06-27","paymentDate":null,"value":0.480451,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHTDY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2353,"buy":0.4118,"hold":0.3529,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4118,"analysts":17,"updateTime":1767762000000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHTDY\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2594266579","title":"国药控股与天士力医药集团达成战略合作 共筑“战略一体化服务”生态新标杆","url":"https://stock-news.laohu8.com/highlight/detail?id=2594266579","media":"国药控股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594266579?lang=zh_cn&edition=fundamental","pubTime":"2025-12-25 20:50","pubTimestamp":1766667043,"startTime":"0","endTime":"0","summary":"近日,国药控股与天士力医药集团举行战略合作沟通会。国药控股副总裁胡立刚,天士力医药党委书记、董事长周辉出席并见证签约。国药控股所属35家子公司负责人,天士力医药集团团队负责人共同参会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225215126a6cee6e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2593348927","title":"刚刚!国药控股董事长正式官宣","url":"https://stock-news.laohu8.com/highlight/detail?id=2593348927","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593348927?lang=zh_cn&edition=fundamental","pubTime":"2025-12-22 13:39","pubTimestamp":1766381987,"startTime":"0","endTime":"0","summary":"国药控股董事长职位调整尘埃落定。国药控股换帅落定同步更新董事名单12月19日,随着国药控股股东特别大会的召开,国药控股此前提名的国药系老将晋斌正式出任董事长。目前,国药控股最新董事名单已同步更新,具体角色与职能如下:营收承压亟待破局已开启多项合作目前来看,晋斌上任之际,国药控股正面临持续的营收增长压力。强强合作成为国药控股扭转营收颓势的方式之一。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222133956a6bff438&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2589866834","title":"122亿!国药控股大合作来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2589866834","media":"中食药信息网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589866834?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 21:35","pubTimestamp":1764855320,"startTime":"0","endTime":"0","summary":"免费领取10学时视频课程中食药智慧教育管理平台2025年12月03日,复宏汉霖消息称,将重续与国药控股经销合作,合作期限为2026年1月1日至2028年12月31日。2023年-2025年9月,国药控股分别完成了19.17亿元、20.40亿元以及16.93亿元的销售额。在此背景下,国药控股与复宏汉霖再次达成合作,未来三年的产品销售总额上限高达122.24亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251205021829a4cd1d17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2589834850","title":"国药控股(湖南)医药创新产业园即将投产","url":"https://stock-news.laohu8.com/highlight/detail?id=2589834850","media":"红网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589834850?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 16:49","pubTimestamp":1764838153,"startTime":"0","endTime":"0","summary":"国药控股(湖南)医药创新产业园作为国药控股湖南有限公司布局医药健康供应链的重点项目,国药控股(湖南)医药创新产业园于2024年4月正式开工建设,核心定位为现代化、智慧化医药健康产业供应链枢纽与服务平台,建成后将进一步完善区域医药供应链体系,提升公共卫生应急保障能力。相较于一期项目,国药控股(湖南)医药创新产业园在功能升级、技术应用、服务效能上实现质的飞跃。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204165227a72362b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SHTDY","BK4175"],"gpt_icon":0},{"id":"2589983486","title":"复宏汉霖重续与国药控股经销协议 年度上限逐年递增","url":"https://stock-news.laohu8.com/highlight/detail?id=2589983486","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589983486?lang=zh_cn&edition=fundamental","pubTime":"2025-12-04 10:03","pubTimestamp":1764813828,"startTime":"0","endTime":"0","summary":"12月3日,复宏汉霖(02696)发布公告,宣布与国药控股的经销框架协议(2025重续)已达成,该协议的初始期限自2023年1月1日起至2025年12月31日止,现已自动续期三年,新的协议有效期自2026年1月1日至2028年12月31日。根据协议,复宏汉霖将继续向国药控股集团销售其产品,预计在2026年、2027年及2028年,每年的交易金额上限分别为38.7亿元、39.01亿元及44.53亿元。过去的交易金额显示,2023年和2024年期间,复宏汉霖自国药控股收到的销售收入分别约为19.17亿元及20.41亿元,而截至2025年9月30日的九个月内,销售金额约为16.93亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204100744a4cb8520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2588101775","title":"国药控股董事长换人!","url":"https://stock-news.laohu8.com/highlight/detail?id=2588101775","media":"制药在线","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588101775?lang=zh_cn&edition=fundamental","pubTime":"2025-12-01 11:39","pubTimestamp":1764560346,"startTime":"0","endTime":"0","summary":"国药控股董事长赵炳祥将辞职国药系老将晋斌接棒11月28日,国药控股发布公告,由于工作安排原因,赵炳祥已向董事会提出辞任非执行董事、董事会董事长、董事会提名委员会主席、董事会战略与投资委员会主席、董事会法律合规与环境、社会及治理委员会委员及公司授权代表职务。国药控股的零售业务增速并未形成绝 对优势。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011139169523d4fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512011139169523d4fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2582375132","title":"美国OTC市场国药控股盘中异动 股价大涨5.44%报13.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582375132","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582375132?lang=zh_cn&edition=fundamental","pubTime":"2025-11-11 23:34","pubTimestamp":1762875294,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日23时34分,美国OTC市场国药控股股票出现异动,股价急速上涨5.44%。美国OTC市场国药控股股票所在的医疗销售行业中,整体跌幅为0.43%。美国OTC市场国药控股公司简介:国药控股股份有限公司成立于2003年,是中国最大的药品和医疗器械批发商和零售商,2009年在香港联交所上市。截至2024年底,国药控股最大的业务部门是药品分销,占其总收入的70%以上。目前,医疗器械分销占国药控股总收入的20%以上。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111233454a6f25546&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0},{"id":"2565330742","title":"国药控股相关公司新增一项122.34万元的招标项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565330742","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565330742?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 23:50","pubTimestamp":1757001000,"startTime":"0","endTime":"0","summary":"(来源:快查一企业中标了)快查APP显示,国药控股相关公司国药控股菱商医院管理服务(上海)有限公司于2025年9月4日发布一则招标信息,项目名称为国药控股菱商医院管理服务(上海)有限公司医院智能管理设备租赁服务项目招标公告,预算金额为122.34万元。快查股权穿透数据显示,该公司由国药控股持股,出资比例为60%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090423572497780183&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1197","SHTDY","BK1515","LU0640798160.USD","LU1115378108.SGD","BK1500","01099"],"gpt_icon":0},{"id":"2565258078","title":"国药控股天和吉林医药有限公司中标吉林大学第二医院激光光学系统采购项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2565258078","media":"DoNews","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2565258078?lang=zh_cn&edition=fundamental","pubTime":"2025-09-04 13:25","pubTimestamp":1756963503,"startTime":"0","endTime":"0","summary":"天眼查App显示,2025年9月3日,吉林大学第二医院激光光学系统采购项目公布中标结果。中标供应商为国药控股天和吉林医药有限公司,中标金额为35万元。采购人吉林大学第二医院位于吉林省长春市,本次采购项目内容为激光光学系统设备的采购。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025090413264195128626&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHTDY"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}